177 related articles for article (PubMed ID: 19412432)
1. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.
Nimmagadda S; Glunde K; Pomper MG; Bhujwalla ZM
Neoplasia; 2009 May; 11(5):477-84. PubMed ID: 19412432
[TBL] [Abstract][Full Text] [Related]
2. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
[TBL] [Abstract][Full Text] [Related]
3. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression.
Ramírez de Molina A; Báñez-Coronel M; Gutiérrez R; Rodríguez-González A; Olmeda D; Megías D; Lacal JC
Cancer Res; 2004 Sep; 64(18):6732-9. PubMed ID: 15374991
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
Arlauckas SP; Popov AV; Delikatny EJ
Mol Cancer Ther; 2014 Sep; 13(9):2149-58. PubMed ID: 25028471
[TBL] [Abstract][Full Text] [Related]
5. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
[TBL] [Abstract][Full Text] [Related]
6. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
Ramírez de Molina A; Gutiérrez R; Ramos MA; Silva JM; Silva J; Bonilla F; Sánchez JJ; Lacal JC
Oncogene; 2002 Jun; 21(27):4317-22. PubMed ID: 12082619
[TBL] [Abstract][Full Text] [Related]
7. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.
Al-Saffar NM; Jackson LE; Raynaud FI; Clarke PA; Ramírez de Molina A; Lacal JC; Workman P; Leach MO
Cancer Res; 2010 Jul; 70(13):5507-17. PubMed ID: 20551061
[TBL] [Abstract][Full Text] [Related]
8. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and phospholipase D assay.
Al-Saeedi F; Smith T; Welch A
Anticancer Res; 2007; 27(2):901-6. PubMed ID: 17465218
[TBL] [Abstract][Full Text] [Related]
9. Choline kinase: an important target for cancer.
Janardhan S; Srivani P; Sastry GN
Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
[TBL] [Abstract][Full Text] [Related]
10. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
11. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.
Huang C; Hydo LM; Liu S; Miller RT
Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891
[TBL] [Abstract][Full Text] [Related]
12. Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR.
Gabellieri C; Beloueche-Babari M; Jamin Y; Payne GS; Leach MO; Eykyn TR
NMR Biomed; 2009 May; 22(4):456-61. PubMed ID: 19156696
[TBL] [Abstract][Full Text] [Related]
13. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
14. Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.
Gallego-Ortega D; Ramirez de Molina A; Ramos MA; Valdes-Mora F; Barderas MG; Sarmentero-Estrada J; Lacal JC
PLoS One; 2009 Nov; 4(11):e7819. PubMed ID: 19915674
[TBL] [Abstract][Full Text] [Related]
15. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas.
Ma W; Wang S; Zhang T; Zhang EY; Zhou L; Hu C; Yu JJ; Xu G
J Pharm Biomed Anal; 2018 Jun; 155():148-156. PubMed ID: 29631075
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.
Ramírez de Molina A; Rodríguez-González A; Gutiérrez R; Martínez-Piñeiro L; Sánchez J; Bonilla F; Rosell R; Lacal J
Biochem Biophys Res Commun; 2002 Aug; 296(3):580-3. PubMed ID: 12176020
[TBL] [Abstract][Full Text] [Related]
17. Use of ¹¹C-Choline positron emission tomography/computed tomography to investigate the mechanism of choline metabolism in lung cancer.
Huang Z; Rui J; Li X; Meng X; Liu Q
Mol Med Rep; 2015 May; 11(5):3285-90. PubMed ID: 25591716
[TBL] [Abstract][Full Text] [Related]
18. Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors.
Arlauckas SP; Kumar M; Popov AV; Poptani H; Delikatny EJ
Oncotarget; 2017 Mar; 8(10):16518-16530. PubMed ID: 28157707
[TBL] [Abstract][Full Text] [Related]
19. Choline kinase: An underappreciated rheumatoid arthritis therapeutic target.
Miriam Jose A; Rasool M
Life Sci; 2022 Nov; 309():121031. PubMed ID: 36206833
[TBL] [Abstract][Full Text] [Related]
20. ChoK-ing the Pathogenic Bacteria: Potential of Human Choline Kinase Inhibitors as Antimicrobial Agents.
Khalifa M; Few LL; See Too WC
Biomed Res Int; 2020; 2020():1823485. PubMed ID: 32695809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
